How Common is Neurosyphilis?
Neurosyphilis occurs in approximately 2.4% of individuals with positive syphilis serology who undergo lumbar puncture evaluation, though the true population prevalence is difficult to establish due to variable testing practices and the frequent occurrence of asymptomatic disease. 1
Epidemiologic Context
The incidence of neurosyphilis varies significantly by population and testing approach:
In high-risk populations: A study from Australia's Northern Territory found an annual incidence of 2.47 per 100,000 person-years in Indigenous populations and 0.95 per 100,000 in non-Indigenous populations (rate ratio 2.60), demonstrating marked disparities 1
Among syphilis-positive patients: When lumbar punctures were performed on individuals with positive treponemal tests, 35% were diagnosed with neurosyphilis (either definite or probable), highlighting that CNS involvement may be more common than historically appreciated when actively sought 1
Historical estimates: Approximately 5,000 new cases of neurosyphilis may occur annually in the United States, though this estimate dates from 1981 and current figures are likely different given the resurgence of syphilis 2
Key Clinical Considerations
Neurosyphilis Can Occur at Any Stage
Neurosyphilis is not confined to late-stage disease and can develop at any point during syphilis infection 3. The CDC guidelines emphasize that:
- HIV-infected patients with early syphilis may be at increased risk for neurologic complications, though the magnitude of this risk is likely minimal 3
- CSF abnormalities (elevated protein and mononuclear pleocytosis) are common in early syphilis even without neurologic symptoms 3
Risk Factors for Neurosyphilis Development
Several factors increase the likelihood of neurosyphilis:
- Higher serum nontreponemal titers (particularly RPR ≥1:32) consistently predict increased neurosyphilis risk 3
- HIV infection with CD4 count ≤350 cells/µL is associated with higher rates of CNS involvement 3
- Advanced immunosuppression may accelerate progression of syphilitic disease 3
The Diagnostic Challenge
Neurosyphilis is frequently underdiagnosed and undertreated, with critical implications:
- 60-70% of probable neurosyphilis cases were not treated appropriately in one study, often due to reliance on negative CSF VDRL results despite clinical suspicion 1
- The CSF VDRL is specific but not sensitive—a nonreactive test does not exclude neurosyphilis 3
- Neurosyphilis presentations are increasingly atypical, with dementia being the most common manifestation (58.3%), followed by epilepsy (16.7%), psychosis (12.5%), and movement disorders 1, 4
Contemporary Epidemiologic Trends
The incidence of neurosyphilis is increasing worldwide, driven by:
- Expansion of men who have sex with men populations 4
- HIV coinfection 4
- Overall resurgence of syphilis across diverse populations 5, 6
Recent epidemics in high-income countries have been accompanied by increases in neurological involvement 6. The spectrum of disease has shifted from the pre-antibiotic era, with general paresis and tabes dorsalis becoming relatively rare, while seizures, neuro-ophthalmic symptoms, stroke, and acute meningoencephalitis are now the most common manifestations 2.
Clinical Pitfalls
Common errors that lead to missed diagnoses include:
- Excluding neurosyphilis based on negative nontreponemal serum tests (VDRL/RPR)—these are negative in more than one-third of neurosyphilis patients 2
- Relying solely on CSF VDRL, which lacks sensitivity 3
- Failing to consider neurosyphilis in the differential diagnosis of neurologic disease, particularly in HIV-infected persons 3
- Not recognizing that normal CSF findings do not exclude active neurosyphilis 2
Neurosyphilis should be considered a treatable cause of secondary movement disorders, dementia, stroke, and psychiatric presentations, with marked improvement possible in 44.7% of cases and partial recovery in 34.2% when appropriately treated 7.